no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Abbreviations of chemotherapeutic combinations
|
|
|
2009 |
3 |
4 |
p. IV-VI nvt p. |
article |
2 |
Abbreviations of drugs
|
|
|
2009 |
3 |
4 |
p. I-III nvt p. |
article |
3 |
Anti-angiogenesis approach to genitourinary cancer treatment
|
Aragon-Ching, Jeanny B. |
|
2009 |
3 |
4 |
p. 182-188 7 p. |
article |
4 |
Biological Abbreviations
|
|
|
2009 |
3 |
4 |
p. VII-X nvt p. |
article |
5 |
Copyright
|
|
|
2009 |
3 |
4 |
p. ii- 1 p. |
article |
6 |
COX-2 inhibitors and colorectal cancer: The end or just a new beginning
|
Meyerhardt, Jeffrey A. |
|
2009 |
3 |
4 |
p. 154-156 3 p. |
article |
7 |
Development of novel agents for bladder cancer
|
Hahn, Noah M. |
|
2009 |
3 |
4 |
p. 160-169 10 p. |
article |
8 |
Editorial Board
|
|
|
2009 |
3 |
4 |
p. i- 1 p. |
article |
9 |
Immunomodulatory agents in oncology
|
Zimmerman, Todd |
|
2009 |
3 |
4 |
p. 170-181 12 p. |
article |
10 |
News Round-Up
|
|
|
2009 |
3 |
4 |
p. 147-153 7 p. |
article |
11 |
Novel therapeutics in breast cancer—Looking to the future
|
Vora, Tushar |
|
2009 |
3 |
4 |
p. 189-205 17 p. |
article |
12 |
NSC-numbers
|
|
|
2009 |
3 |
4 |
p. XI- 1 p. |
article |
13 |
TROG 96.01: TTBF and PSAdt as surrogates for disease specific mortality
|
Hoimes, Christopher J. |
|
2009 |
3 |
4 |
p. 157-159 3 p. |
article |